114 studies found for:    "Leishmaniasis"
Show Display Options
Rank Status Study
1 Unknown  Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Intervention: Drug: Miltefosine
2 Recruiting Low Antimonial Dosage in American Mucosal Leishmaniasis
Conditions: Mucosal Leishmaniasis;   Mucocutaneous Leishmaniasis
Intervention: Drug: Meglumine antimoniate
3 Completed Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
Conditions: Leishmaniasis;   Cutaneous Leishmaniasis
Interventions: Drug: pentavalent antimony;   Procedure: cryotherapy;   Drug: placebo cream
4 Active, not recruiting A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
Condition: Post-kala-azar Dermal Leishmaniasis
Intervention: Drug: Mitefosine
5 Recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Leishmaniasis, Mucocutaneous;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
6 Unknown  Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Conditions: Leishmaniasis, Cutaneous;   Leishmaniasis, Mucocutaneous
Intervention: Drug: sodium stibogluconate (Pentostam)
7 Completed A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.
Conditions: Visceral Leishmaniasis;   Leishmaniasis, Visceral
Intervention: Drug: sitamaquine
8 Completed Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
Condition: Leishmaniasis, Mucocutaneous
Intervention: Biological: Leish-111f + MPL-SE vaccine
9 Completed Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
Conditions: Visceral Leishmaniasis;   Post-Kala-Azar Dermal Leishmaniasis
Intervention: Biological: Leish-111f + MPL-SE Adjuvant
10 Completed Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar
Conditions: Visceral Leishmaniasis;   Kala Azar
Intervention: Device: Long Lasting Impregnated Nets (LLIN)
11 Not yet recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
12 Completed Amphotericin B Treatment in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Amphotericin B deoxycholate given as daily administration
13 Completed Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Miltefosine + Imiquimod;   Drug: Miltefosine 150 mg x day + Placebo
14 Withdrawn SCH708980 With and Without AmBisome for Visceral Leishmaniasis
Conditions: Leishmaniasis;   Effects of Immunotherapy
Interventions: Drug: SCH708980 Anti-IL-10 monoclonal;   Drug: AmBisome
15 Completed Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin sulfate
16 Completed Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Condition: Leishmaniasis
Interventions: Drug: allopurinol;   Drug: glucantime
17 Completed Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia
Conditions: Visceral Leishmaniasis;   Malnutrition
18 Active, not recruiting Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Pentoxifylline;   Drug: Placebo
19 Recruiting Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
20 Unknown  Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: N-metil glucamine;   Drug: Azithromycin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years